CLINICAL_TRIALS ClinicalTrials.gov record update

Recombinant Anti-EGFR Monoclonal Antibody（SCT200） in Patients With Relapsed or Metastatic Triple Receptor Negative Breast Cancer : a Phase Ⅱ, Open-label, Single-arm, Multicenter Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03692689
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:08.366858+00:00
Published At: 2018-10-02T00:00:00+00:00
Record Updated At: 2018-10-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Triple Negative Breast Neoplasms"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-10-02"
protocolSection.identificationModule.nctId: "NCT03692689"
protocolSection.identificationModule.officialTitle: "Recombinant Anti-EGFR Monoclonal Antibody\uff08SCT200\uff09 in Patients With Relapsed or Metastatic Triple Receptor Negative Breast Cancer : a Phase \u2161, Open-label, Single-arm, Multicenter Study"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.